Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Methicillin-Resistant Staphylococcus Aureus Drugs Market
Methicillin Resistant Staphylococcus aureus (MRSA) Drugs Market size was valued at USD 2.21 billion in 2024 and is anticipated to reach USD 3.29 billion by 2032, at a CAGR of 5.11% during the forecast period.
-
Europe Anesthesia Breathing Filters Market
The Europe Anesthesia Breathing Filters Market size was valued at USD 51.42 million in 2018 to USD 62.38 million in 2024 and is anticipated to reach USD 80.64 million by 2032, at a CAGR of 2.98% during the forecast period.
-
DNA Synthesizer Market
The DNA Synthesizer Market size was valued at USD 5138.1 million in 2024 and is anticipated to reach USD 22389.2 million by 2032, at a CAGR of 20.2% during the forecast period (2024-2032).
-
Single Cell Omics Market
Single Cell Omics Market size was valued at USD 1.96 billion in 2024 and is anticipated to reach USD 6.34 billion by 2032, at a CAGR of 15.8% during the forecast period.
-
Montelukast Sodium Market
The montelukast sodium market was valued at USD 519.8 million in 2024 and is projected to reach USD 1,623.6 million by 2032, expanding at a compound annual growth rate (CAGR) of 15.3% from 2024 to 2032.
-
Non-Animal Alternative Testing Market
The non-animal alternative testing market is projected to grow from USD 2020 million in 2024 to USD 4330 million by 2032, registering a 10% CAGR during the forecast period.
-
Opioid Induced Constipation (OIC) Drugs Market
The opioid induced constipation drugs market is projected to grow from USD 2200.8 million in 2024 to USD 3153.8 million by 2032, registering a CAGR of 4.6% during the forecast period.
-
Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market
The non alcoholic steatohepatitis biomarkers market size was valued at USD 1435.3 million in 2024 and is anticipated to reach USD 8945.9 million by 2032, at a CAGR of 25.7 % during the forecast period (2024-2032).
-
Prefilled Formalin Vials Market
Prefilled Formalin Vials Market size was valued at USD 438.1 million in 2024 and is anticipated to reach USD 585.4 million by 2032, at a CAGR of 3.69% during the forecast period.
-
Ophthalmic Loupes Market
The ophthalmic loupes market is projected to grow from USD 542.7 million in 2024 to an estimated USD 960.7 million by 2032, with a compound annual growth rate (CAGR) of 7.4% from 2024 to 2032.
